The allergy treatment market comprises products such as antihistamines, corticosteroids, decongestants and mast cell stabilizers which are used in the treatment of various allergic reactions like food allergy, asthma, sinusitis, eye allergy, skin allergy and other conditions. The growing prevalence of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis has been the major driver for the growth of the allergy treatment market. It is estimated that over 50 million Americans currently suffer from some form of allergy. The increasing global prevalence of allergic diseases and growing awareness about the availability of effective treatment options are further fueling the demand for allergy treatments.

The global allergy treatment market is estimated to be valued at USD 21.19 Bn in 2024 and is expected to reach USD 34.42 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Key Takeaways

Key players operating in the allergy treatment market are Sanofi, Novartis, GSK plc, Johnson and JohnsonServices, Inc., F. Hoffmann-La Roche Ltd., Stallergenes Greer, Dermapharm Holding SE, Nicox, Allergy Therapeutics, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Alembic Pharmaceuticals Limited, ALK-Abelló A/S, Bausch Health Companies Inc., GLENMARK PHARMACEUTICALS LTD., Perrigo Company plc, and Dr Reddy's Laboratories Ltd. Major players are involved in strategic collaborations and new product launches to strengthen their market position.

The increasing burden of allergic diseases and unmet needs represent a massive opportunity for manufacturers to develop novel therapies and devices. Innovation in drug delivery mechanisms, focus on precision medicine and development of immunotherapy are likely to open new avenues.

Growing globalization, rising disposable incomes and urbanization are increasing the risk of spread of Allergy Treatment Market Growth. This has led to significant expansion opportunities for key players in emerging markets of Asia Pacific, Latin America, Middle East and Africa. Companies are undertaking initiatives to enhance access to allergy treatments in these underpenetrated regions.

Market Drivers

The rising incidence rates of allergic disorders across both developed and developing regions is a key factor driving the demand for allergy treatments. According to recent studies, allergic rhinitis affects 10-30% of the global population. Similarly, the prevalence of asthma and atopic dermatitis is on the rise. Growing environmental pollution levels and lifestyle changes are majorly responsible for escalating allergic disease burden.

Market Restraints

However, the market faces restrictions due to poor access to diagnosis and treatment in low-income countries. Also, the development of newer drugs involves huge capital investment and regulatory approvals, deterring many small to mid-sized players. Patent expirations of blockbuster drugs further intensify the competition. Finally, lack of disease-modifying treatments and risk of drug resistance limits the scope of the market to some extent.

Segment Analysis
The allergy treatment market is dominated by the antihistamines sub segment. Antihistamines are the most common form of treatment prescribed for allergies such as seasonal allergies and food allergies. They work by blocking the effects of histamine, the main chemical mediator involved in allergic inflammation. Oral tablets and syrups are the preferred dosage forms for antihistamines due to ease of administration.

The immunotherapy sub segment is expected to grow at a fast pace over the forecast period. Immunotherapy, also known as allergy shots, aims to desensitize the immune system to specific allergens. It is highly effective especially for seasonal allergies. The success rate of immunotherapy is around 80% and its benefits can last for 3-5 years after treatment completion. Hence more patients and doctors are willing to opt for it despite the longer treatment duration required.

Global Analysis
The North America region currently dominates the Allergy Treatment Market Regional Analysis owing to high allergy prevalence and developed healthcare infrastructure in countries like United States and Canada. As per recent studies, over 50 million people in the United States suffer from allergies each year. The region is expected to continue its dominance over the forecast period due to growing adoption of new product innovations.

Asia Pacific region is poised to showcase highest growth rate during the forecast period. Presence of large patient pools in highly populous countries such as India and China will drive market growth. Additionally, rising incomes are enhancing affordability of newer and advanced treatments in Asia Pacific. Improving regulatory guidelines are also encouraging global key players to expand their reach in the region.

Discover the Report for More Insights, Tailored to Your Language:

• Japanese

• Korean

About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)